Growth/differentiation factor 15 (GDF15) expression in the heart after myocardial infarction and cardioprotective effect of pre-ischemic rGDF15 administration

被引:2
|
作者
Dogon, Geoffrey [1 ]
Rigal, Eve [1 ]
Potel, Eliot [1 ]
Josse, Marie [1 ]
Rochette, Luc [1 ]
Bejot, Yannick [1 ,2 ]
Vergely, Catherine [1 ]
机构
[1] Univ Burgundy, Fac Hlth Sci, Res Team Physiopathol & Epidemiol Cerebro Cardiova, 7 Bd Jeanne Arc, F-21000 Dijon, France
[2] Dijon Univ Hosp, Dept Neurol, Dijon, France
来源
SCIENTIFIC REPORTS | 2024年 / 14卷 / 01期
关键词
GDF-15; Ischemia-reperfusion injury; Heart; Preconditioning; Cardioprotection; GROWTH-DIFFERENTIATION FACTOR-15; ISCHEMIA/REPERFUSION INJURY; ISCHEMIA-REPERFUSION; RECEPTOR; PATHWAY; BETA; MORTALITY; INSIGHTS; EVENTS; STRESS;
D O I
10.1038/s41598-024-63880-5
中图分类号
O [数理科学和化学]; P [天文学、地球科学]; Q [生物科学]; N [自然科学总论];
学科分类号
07 ; 0710 ; 09 ;
摘要
Growth/differentiation factor-15 (GDF15) is considered an unfavourable prognostic biomarker for cardiovascular disease in clinical data, while experimental studies suggest it has cardioprotective potential. This study focuses on the direct cardiac effects of GDF15 during ischemia-reperfusion injury in Wistar male rats, employing concentrations relevant to patients at high cardiovascular risk. Initially, we examined circulating levels and heart tissue expression of GDF15 in rats subjected to ischemia-reperfusion and sham operations in vivo. We then evaluated the cardiac effects of GDF15 both in vivo and ex vivo, administering recombinant GDF15 either before 30 min of ischemia (preconditioning) or at the onset of reperfusion (postconditioning). We compared infarct size and cardiac contractile recovery between control and rGDF15-treated rats. Contrary to our expectations, ischemia-reperfusion did not increase GDF15 plasma levels compared to sham-operated rats. However, cardiac protein and mRNA expression increased in the infarcted zone of the ischemic heart after 24 h of reperfusion. Notably, preconditioning with rGDF15 had a cardioprotective effect, reducing infarct size both in vivo (65 +/- 5% in control vs. 42 +/- 6% in rGDF15 groups) and ex vivo (60 +/- 4% in control vs. 45 +/- 4% in rGDF15 groups), while enhancing cardiac contractile recovery ex vivo. However, postconditioning with rGDF15 did not alter infarct size or the recovery of contractile parameters in vivo or ex vivo. These novel findings reveal that the short-term exogenous administration of rGDF15 before ischemia, at physiologically relevant levels, protects the heart against ischemia-reperfusion injury in both in vivo and ex vivo settings. The ex vivo results indicate that rGDF15 operates independently of the inflammatory, endocrine and nervous systems, suggesting direct and potent cardioprotective properties against ischemia-reperfusion injury.
引用
收藏
页数:14
相关论文
共 50 条
  • [1] Association of growth differentiation factor 15 (GDF15) polymorphisms with serum GDF15 and ferritin levels in β-thalassemia
    Athiyarath, Rekha
    George, Biju
    Mathews, Vikram
    Srivastava, Alok
    Edison, Eunice S.
    ANNALS OF HEMATOLOGY, 2014, 93 (12) : 2093 - 2095
  • [2] Association of growth differentiation factor 15 (GDF15) polymorphisms with serum GDF15 and ferritin levels in β-thalassemia
    Rekha Athiyarath
    Biju George
    Vikram Mathews
    Alok Srivastava
    Eunice S. Edison
    Annals of Hematology, 2014, 93 : 2093 - 2095
  • [3] Growth differentiation factor 15 (GDF15) expression in astrocytes after excitotoxic lesion in the mouse hippocampus
    Kim, S.
    Yi, M. -H.
    Zhang, E.
    Baek, H.
    Shin, N.
    Oh, S. -H.
    Kim, D. W.
    GLIA, 2015, 63 : E110 - E110
  • [4] Morphological Effects on Expression of Growth Differentiation Factor 15 (GDF15), a Marker of Metastasis
    Yong, Koh Meng Aw
    Zeng, Yu
    Vindivich, Donald
    Phillip, Jude M.
    Wu, Pei-Hsun
    Wirtz, Denis
    Getzenberg, Robert H.
    JOURNAL OF CELLULAR PHYSIOLOGY, 2014, 229 (03) : 362 - 373
  • [5] Exogenous Growth Differentiation Factor 15 (GDF15) exerts direct cardioprotective properties towards myocardial ischemia reperfusion injury
    Dogon, G.
    Rigal, E. R.
    Rochette, L. R.
    Bejot, Y. B.
    Vergely, C. V.
    CARDIOVASCULAR RESEARCH, 2022, 118 (SUPPL 1)
  • [6] Overview of growth differentiation factor 15 (GDF15) in metabolic diseases
    Li, Jian
    Hu, Xiangjun
    Xie, Zichuan
    Li, Jiajin
    Huang, Chen
    Huang, Yan
    BIOMEDICINE & PHARMACOTHERAPY, 2024, 176
  • [7] ROLE OF GDF15 (GROWTH AND DIFFERENTIATION FACTOR 15) IN PULMONARY OXYGEN TOXICITY
    Lingappan, K.
    Tiwari, K.
    Moorthy, B.
    JOURNAL OF INVESTIGATIVE MEDICINE, 2015, 63 (02) : 447 - 447
  • [8] The role of GDF15 (growth/differentiation factor 15) during prostate carcinogenesis
    Sadasivan, Sudha M.
    Chen, Yalei
    Gupta, Nilesh S.
    Taneja, Kanika
    Maresh, Scott A.
    Gonzalez, Alysa
    Han, Xiaoxia
    Wu, Kuan-Han Hank
    Chitale, Dhananjay
    Rundle, Andrew
    Tang, Deliang
    Rybicki, Benjamin A.
    CANCER RESEARCH, 2018, 78 (13)
  • [9] Role of GDF15 (growth and differentiation factor 15) in pulmonary oxygen toxicity
    Tiwari, Kirti Kumar
    Moorthy, Bhagavatula
    Lingappan, Krithika
    TOXICOLOGY IN VITRO, 2015, 29 (07) : 1369 - 1376
  • [10] Effect of sleeve gastrectomy on plasma growth differentiation factor-15 (GDF15) in human
    Dolo, Ponnie Robertlee
    Yao, Libin
    Liu, Peng Peng
    Widjaja, Jason
    Meng, Song
    Li, Chao
    Zhu, Xiaocheng
    AMERICAN JOURNAL OF SURGERY, 2020, 220 (03): : 725 - 730